A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

BACKGROUND: To evaluate activity and tolerability of two anthracycline-containing regimens as first-line treatment for anthracycline-naïve relapsed breast cancer patients. METHODS: Patients with relapsed breast cancer not previously treated with adjuvant anthracyclines were randomly assigned to epir...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Vici, Patrizia, Colucci, Giuseppe, Giotta, Francesco, Sergi, Domenico, Filippelli, Gianfranco, Perri, Pasquale, Botti, Claudio, Vizza, Enrico, Carpino, Armando, Pizzuti, Laura, Latorre, Agnese, Giannarelli, Diana, Lopez, Massimo, Di Lauro, Luigi
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082232/
https://ncbi.nlm.nih.gov/pubmed/21481280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-39
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi